Header Logo

Connection

ABDI RASEKH to Treatment Outcome

Back to Details
This is a "connection" page, showing publications ABDI RASEKH has written about Treatment Outcome.
ABDI RASEKH
Connection Strength
0.481
Treatment Outcome
  1. Left Atrial Appendage Closure and Pulmonary Vein Isolation. Tex Heart Inst J. 2020 02; 47(1):60-62.
    View in: PubMed
    Score: 0.052
  2. Closure of Left Atrial Appendage to Prevent Stroke: Devices and Status. Tex Heart Inst J. 2018 06; 45(3):172-174.
    View in: PubMed
    Score: 0.046
  3. Update on Atrial Fibrillation. Tex Heart Inst J. 2016 Oct; 43(5):412-414.
    View in: PubMed
    Score: 0.041
  4. Where We Stand on Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. Tex Heart Inst J. 2016 Aug; 43(4):320-3.
    View in: PubMed
    Score: 0.041
  5. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013 Mar 15; 111(6):869-73.
    View in: PubMed
    Score: 0.032
  6. Biventricular intracardiac device implanted in a patient with persistent left superior vena cava. Tex Heart Inst J. 2012; 39(4):586-7.
    View in: PubMed
    Score: 0.030
  7. Stroke prevention in nonvalvular atrial fibrillation. Tex Heart Inst J. 2011; 38(4):350-2.
    View in: PubMed
    Score: 0.028
  8. Catheter-based ablation of atrial fibrillation: a brief overview. Tex Heart Inst J. 2011; 38(4):361-3.
    View in: PubMed
    Score: 0.028
  9. Stent-graft exclusion of multiple symptomatic coronary artery fistulae. Tex Heart Inst J. 2007; 34(2):199-202.
    View in: PubMed
    Score: 0.021
  10. Characterization of AV Nodal Left Inferior Extension by Use of High-Density Mapping and Voltage-Time Relationship. J Cardiovasc Electrophysiol. 2026 May; 37(5):925-929.
    View in: PubMed
    Score: 0.020
  11. Risk Stratification in Patients Who Underwent Percutaneous Left Atrial Appendage Occlusion. Am J Cardiol. 2023 08 01; 200:50-56.
    View in: PubMed
    Score: 0.016
  12. Slow-pathway visualization by using voltage-time relationship: A novel technique for identification and fluoroless ablation of atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol. 2020 06; 31(6):1430-1435.
    View in: PubMed
    Score: 0.013
  13. Long-term clinical outcomes from real-world experience of left atrial appendage exclusion with LARIAT device. J Cardiovasc Electrophysiol. 2019 12; 30(12):2849-2857.
    View in: PubMed
    Score: 0.013
  14. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies. JACC Clin Electrophysiol. 2017 12 26; 3(13):1475-1483.
    View in: PubMed
    Score: 0.011
  15. Impact of Periprocedural Colchicine on Postprocedural Management in Patients Undergoing a Left Atrial Appendage Ligation Using LARIAT. J Cardiovasc Electrophysiol. 2016 Jan; 27(1):60-4.
    View in: PubMed
    Score: 0.010
  16. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications. Heart Rhythm. 2015 Jul; 12(7):1501-7.
    View in: PubMed
    Score: 0.009
  17. Safety and effectiveness of compassionate use of LARIAT? device for epicardial ligation of anatomically complex left atrial appendages. J Interv Card Electrophysiol. 2015 Jan; 42(1):11-9.
    View in: PubMed
    Score: 0.009
  18. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices. Heart Rhythm. 2015 Jan; 12(1):52-9.
    View in: PubMed
    Score: 0.009
  19. Phased RF ablation in persistent atrial fibrillation. Heart Rhythm. 2014 Feb; 11(2):202-9.
    View in: PubMed
    Score: 0.008
  20. Exclusion of the left atrial appendage to prevent stroke in cases of atrial fibrillation. Tex Heart Inst J. 2012; 39(4):535-7.
    View in: PubMed
    Score: 0.007
  21. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol. 2011 Feb; 34(2):133-42.
    View in: PubMed
    Score: 0.007
  22. Tachycardia-mediated cardiomyopathy and the permanent form of junctional reciprocating tachycardia. Tex Heart Inst J. 2010; 37(6):695-8.
    View in: PubMed
    Score: 0.006
  23. Coalescence of splines on a basket mapping catheter during ablation using a closed-loop irrigation catheter. Europace. 2009 Feb; 11(2):258-9.
    View in: PubMed
    Score: 0.006
  24. Cardiac resynchronization therapy may improve symptoms of congestive heart failure in patients without electrical or mechanical dyssynchrony. Europace. 2009 Jan; 11(1):86-8.
    View in: PubMed
    Score: 0.006
  25. Interatrial conduction measured during biventricular pacemaker implantation accurately predicts optimal paced atrioventricular intervals. J Cardiovasc Electrophysiol. 2007 Mar; 18(3):290-5.
    View in: PubMed
    Score: 0.005
  26. Slow pathway ablation decreases vulnerability to pacing-induced atrial fibrillation: Possible role of vagal denervation. Pacing Clin Electrophysiol. 2006 Nov; 29(11):1234-9.
    View in: PubMed
    Score: 0.005
  27. Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter. Am J Cardiol. 2000 Jan 01; 85(1):112-4, A9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.